1885 related articles for article (PubMed ID: 25400447)
1. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and liver diseases.
Minemura M; Shimizu Y
World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
[TBL] [Abstract][Full Text] [Related]
3. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli.
van Baarlen P; Wells JM; Kleerebezem M
Trends Immunol; 2013 May; 34(5):208-15. PubMed ID: 23485516
[TBL] [Abstract][Full Text] [Related]
4. Gut inflammation and microbiome in spondyloarthritis.
Kabeerdoss J; Sandhya P; Danda D
Rheumatol Int; 2016 Apr; 36(4):457-68. PubMed ID: 26719306
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease, gut bacteria and probiotic therapy.
Reiff C; Kelly D
Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
[TBL] [Abstract][Full Text] [Related]
7. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
Miura K; Ohnishi H
World J Gastroenterol; 2014 Jun; 20(23):7381-91. PubMed ID: 24966608
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
Blum S; Schiffrin EJ
Curr Issues Intest Microbiol; 2003 Sep; 4(2):53-60. PubMed ID: 14503689
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
Vanderpool C; Yan F; Polk DB
Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
[TBL] [Abstract][Full Text] [Related]
10. The effect of probiotics and gut microbiota on Th17 cells.
Tanabe S
Int Rev Immunol; 2013; 32(5-6):511-25. PubMed ID: 24094077
[TBL] [Abstract][Full Text] [Related]
11. The role of the microbiome in gastrointestinal inflammation.
Sanders DJ; Inniss S; Sebepos-Rogers G; Rahman FZ; Smith AM
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076695
[TBL] [Abstract][Full Text] [Related]
12. [Probiotics for inflammatory bowel disease].
Iizuka H; Takaishi H; Hibi T
Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
[TBL] [Abstract][Full Text] [Related]
13. Probiotics, gut microbiota, and their influence on host health and disease.
Sánchez B; Delgado S; Blanco-Míguez A; Lourenço A; Gueimonde M; Margolles A
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27500859
[TBL] [Abstract][Full Text] [Related]
14. Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases.
Plaza-Díaz J; Ruiz-Ojeda FJ; Gil-Campos M; Gil A
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303974
[TBL] [Abstract][Full Text] [Related]
15. Probiotics and Liver Disease: Where Are We Now and Where Are We Going?
Elzouki AN
J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S188-S190. PubMed ID: 27741172
[TBL] [Abstract][Full Text] [Related]
16. Health, probiotics, and inflammation.
Mengheri E
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S177-8. PubMed ID: 18685508
[TBL] [Abstract][Full Text] [Related]
17. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature.
Giuffrè M; Campigotto M; Campisciano G; Comar M; Crocè LS
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G889-G906. PubMed ID: 32146836
[TBL] [Abstract][Full Text] [Related]
18. The Gut Microbiota in Celiac Disease and probiotics.
Chibbar R; Dieleman LA
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
[TBL] [Abstract][Full Text] [Related]
19. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
Babickova J; Gardlik R
World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
[TBL] [Abstract][Full Text] [Related]
20. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
